{"id":"NCT03706456","sponsor":"Takeda","briefTitle":"Phase 3 Study of Cx601 in Participants With Complex Perianal Fistulising Crohn's Disease","officialTitle":"A Phase 3, Multicenter, Open-Label, Uncontrolled Study to Evaluate the Efficacy and Safety of Cx601 in the Treatment of Complex Perianal Fistulas in Adult Patients With Crohn's Disease","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2019-03-06","primaryCompletion":"2020-07-20","completion":"2023-02-10","firstPosted":"2018-10-16","resultsPosted":"2021-10-07","lastUpdate":"2024-06-10"},"enrollment":22,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Complex Perianal Fistulas in Adult Participants With Crohn's Disease"],"interventions":[{"type":"BIOLOGICAL","name":"Darvadstrocel","otherNames":["Cx601"]}],"arms":[{"label":"Darvadstrocel 24 mL","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to evaluate the efficacy of darvadstrocel for the treatment of complex perianal fistulas in adult participants with Crohn's disease over 24 weeks.","primaryOutcome":{"measure":"Percentage of Participants With Combined Remission of Perianal Fistulising Crohn's Disease (CD) at Week 24","timeFrame":"Week 24","effectByArm":[{"arm":"Darvadstrocel 24 mL","deltaMin":59.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":11,"countries":["Japan"]},"refs":{"pmids":["36149832"],"seeAlso":["https://clinicaltrials.takeda.com/study-detail/5f6b60224db2bf003ab49683"]},"adverseEventsSummary":{"seriousAny":{"events":11,"n":22},"commonTop":["Proctalgia","Anal fistula","Nasopharyngitis","Back pain","Acrochordon"]}}